Pep27anal2
General Information
DRACP ID DRACP00138
Peptide Name Pep27anal2
Sequence MWKWFHNVLSWWWLLADKRPARDYNRK
Sequence Length 27
UniProt ID Not available
PubChem CID Not available
Origin S. pneumoniae
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
OCI-AML-2 | Adult acute myeloid leukemia; Acute myeloid leukemia | Leukemia | IC50=29 µM | MTT assay | 22.5 min | 1 |
HL-60 | Adult acute myeloid leukemia; Acute myeloid leukemia | Leukemia | IC50=20 µM | MTT assay | 22.5 min | 1 |
Jurkat | Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia | Leukemia | IC50=23 µM | MTT assay | 22.5 min | 1 |
SNU-601 | Gastric signet ring cell adenocarcinoma | Carcinoma | IC50=25 µM | MTT assay | 22.5 min | 1 |
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | IC50<10 µM | MTT assay | 22.5 min | 1 |
Hemolytic Activity Human RBCs(18% hemolysis at 12.5 μM), Human RBCs(0% hemolysis at 0.19 μM, 0.39 μM, 0.78 μM, 1.56 μM, 3.12 μM, 6.25 μM)
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Pep27anal2 can penetrate the plasma membrane, and then induce apoptosis in both caspase-and cytochrome c-independent manner
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C173H244N48O36S
Absent amino acids CEGIQT
Common amino acids W
Mass 406814
Pl 11.09
Basic residues 7
Acidic residues 2
Hydrophobic residues 12
Net charge 5
Boman Index -6093
Hydrophobicity -98.89
Aliphatic Index 61.48
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 28990
Absorbance 280nm 1115
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 16004618
Title Functional and structural characteristics of anticancer peptide Pep27 analogues
Year 2005
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available